Photo detail

Marty Duvall

Stories this photo appears in:

Trials Combined for Cancer Therapy

HEALTH: Move Expected to Greatly Advance Timelines

San Diego drugmaker Tocagen accelerated its gene cancer therapy into a pivotal Phase 3 trial, which the company estimates will shave off as many as three years from the drug’s development and the U.S. Food and Drug Administration regulatory process.

Tease photo